Not yet registered on PMX
This profile is generated from public regulatory records. The company has not registered on PMX yet, and PMX has not verified it.
- Country
- China
- Region
- Asia
Regulatory licences
- DPLName on licence: 武汉生物制品研究所有限责任公司
Registered products
62 products
Meidujiabenanhongbujiarexueqingshiyanzhenduanshijihe梅毒甲苯胺红不加热血清试验诊断试剂盒120人份Xifuwuxibaobaibaipolianheyimiao吸附无细胞百白破联合疫苗每安瓿1.0ml。每1次人用剂量0.5ml,含无细胞百日咳疫苗效价不低于4.0IU,白喉疫苗效价不低于30IU,破伤风疫苗效价不低于40IU。Xifuwuxibaobaibaipolianheyimiao吸附无细胞百白破联合疫苗每安瓿2.0ml。每1次人用剂量0.5ml,含无细胞百日咳疫苗效价不低于4.0IU,白喉疫苗效价不低于30IU,破伤风疫苗效价不低于40IU。Xifuwuxibaobaibaipolianheyimiao吸附无细胞百白破联合疫苗每安瓿(瓶)0.5ml。每1次人用剂量0.5ml,含无细胞百日咳疫苗效价不低于4.0IU,白喉疫苗效价不低于30IU,破伤风疫苗效价不低于40IU。Renleimianyiquexianbingdukangtizhenduanshijihe人类免疫缺陷病毒抗体诊断试剂盒(酶联免疫法)96人份KangAkangBxuexingdingxingshiji抗A抗B血型定型试剂(单克隆抗体)10ml/支Zhongzuyixingganyanyimiao重组乙型肝炎疫苗(CHO细胞)每安瓿1.0ml。每1次人用剂量为1.0ml,含HBsAg 10μg。Mazhensaixianyanlianhejianduhuoyimiao麻疹腮腺炎联合减毒活疫苗复溶后每安瓿1.0ml。每1次人用剂量为0.5ml,含麻疹活病毒应不低于3.0 lgCCID50,含腮腺炎活病毒应不低于3.7 lgCCID50。Renyongkuangquanbingyimiao人用狂犬病疫苗(Vero细胞)本品每瓶为1.0ml。每1次人用剂量1.0ml,狂犬病疫苗效价不低于2.5IU。Mazhensaixianyanlianhejianduhuoyimiao麻疹腮腺炎联合减毒活疫苗复溶后每瓶0.5ml。每1次人用剂量为0.5ml,含麻疹活病毒应不低于3.0 lgCCID50,含腮腺炎活病毒应不低于3.7 lgCCID50。Dongganrenyongkuangquanbingyimiao冻干人用狂犬病疫苗(Vero细胞)复溶后每瓶0.5ml。每1次人用剂量为0.5ml,狂犬病疫苗效价出品时不低于4.0 IU/剂,有效期内效价不低于2.5 IU/剂。稀释液为灭菌注射用水,每瓶0.5mlYixingnaoyanjianduhuoyimiao乙型脑炎减毒活疫苗复溶后每瓶0.5ml。每1次人用剂量为0.5ml,含乙型脑炎活病毒不低于5.4lgPFU
